Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Cancer

Date Submitted: Nov 9, 2021
Date Accepted: Mar 15, 2022

The final, peer-reviewed published version of this preprint can be found here:

Investigation of Intervention Solutions to Enhance Adherence to Oral Anticancer Medicines in Adults: Overview of Reviews

Dang TH, Forkan ARM, Wickramasinghe N, Jayaraman PP, Alexander M, Burbury K, Schofield P

Investigation of Intervention Solutions to Enhance Adherence to Oral Anticancer Medicines in Adults: Overview of Reviews

JMIR Cancer 2022;8(2):e34833

DOI: 10.2196/34833

PMID: 35475978

PMCID: 9096640

Investigation of intervention solutions to enhance adherence to oral anti-cancer medicines in adults: an overview of reviews

  • Thu Ha Dang; 
  • Abdur Rahim Mohammad Forkan; 
  • Nilmini Wickramasinghe; 
  • Prem Prakash Jayaraman; 
  • Marliese Alexander; 
  • Kate Burbury; 
  • Penelope Schofield

ABSTRACT

Background:

Adherence to anti-cancer medicines is critical for the success of cancer treatments, however, non-adherence is still challenging while evidence of adherence interventions in cancer is limited.

Objective:

This systematic review aimed to synthesise evidence of available reviews of interventions to improve adherence to oral anti-cancer medicines in adult cancer survivors.

Methods:

A comprehensive search was undertaken on seven electronic databases and three oncology journals. Two reviewers independently conducted study selection, quality assessment using AMSTAR 2, and data extraction of selected reviews. The PRISMA-2020 checklist was adapted to report results.

Results:

Twenty-eight reviews were included for a narrative synthesis. The overall quality of systematic reviews was low. Four main adherence-promoting strategies were education, reminder, behaviour and monitoring, and multi-component. Digital technology-based interventions were reported in most reviews (n=26). Few interventions applied theories (n=10), design frameworks (n=2), or engaged stakeholders (n=1) in the development processes. The effectiveness of interventions was inconsistent between and within reviews. However, interventions using multiple adherence-promoting strategies were more likely to be effective than single-strategy interventions (11 reviews). Unidirectional communication (7 reviews) and technology alone (11 reviews) were not sufficient to demonstrate improvement in adherence outcomes. Nurses and pharmacists play a critical role in promoting patients’ adherence to oral cancer therapies, especially with the support of digital technologies (6 reviews).

Conclusions:

Multi-component interventions are potentially effective in promoting patients’ adherence to oral-anti cancer medicines. The seamless integration of digital solutions with direct clinical contacts is likely to be effective in promoting adherence. It is important for future research in developing comprehensive digital adherence interventions to be evidence-based, theory-based, and rigorously evaluated.


 Citation

Please cite as:

Dang TH, Forkan ARM, Wickramasinghe N, Jayaraman PP, Alexander M, Burbury K, Schofield P

Investigation of Intervention Solutions to Enhance Adherence to Oral Anticancer Medicines in Adults: Overview of Reviews

JMIR Cancer 2022;8(2):e34833

DOI: 10.2196/34833

PMID: 35475978

PMCID: 9096640

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.